$CTIC Recent News Insider filings one way to track

New Post Public Reply Private Reply Replies (0) Message Board

Jan 13, 2015 at 9:47 AM

$CTIC Recent News

Insider filings one way to track tricky micro-cap biotechs 11:14 a.m. Oct. 24, 2012 - blogs.marketwatch.com
Friday’s biggest gaining and declining stocks 3:27 p.m. Oct. 5, 2012 - Greg Morcroft
Cell Therapeutics down 21% in premarket 6:15 a.m. Oct. 5, 2012 - Steve Gelsi
Tuesday’s biggest gaining and declining stocks 3:53 p.m. Oct. 2, 2012 - MarketWatch
Cell Therapeutics up 21% in premarket 7:38 a.m. Oct. 2, 2012 - Steve Gelsi
CTIC gets orphan drug status for brain cancer drug 6:37 a.m. Oct. 2, 2012 - MarketWatch.com
Cell Therapeutics: progress with lymphoma Drug 5:59 a.m. Sept. 24, 2012 - MarketWatch.com
Tuesday’s top gaining and declining stocks 3:57 p.m. Sept. 11, 2012 - MarketWatch
Cell Therapeutics soars 24% on EU drug launch 9:12 a.m. Sept. 11, 2012 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 4:01 p.m. Sept. 4, 2012 - Greg Morcroft
Updates, advisories and surprises 4:01 p.m. July 31, 2012 - MarketWatch
Cell Therapeutics announces stock placement 10:45 a.m. July 31, 2012 - Val Brickates Kennedy
Friday’s biggest gaining and declining stocks 4:21 p.m. Feb. 17, 2012 - Kate Gibson
Monday’s biggest gaining and declining stocks 4:49 p.m. Jan. 30, 2012 - Kate Gibson
Cell Therapeutics pulls application; shares slump 1:25 p.m. Jan. 30, 2012 - MarketWatch.com
Stocks to watch Monday: Blue Coat, Cooper 4:35 p.m. Dec. 9, 2011 - William Spain
Friday’s biggest gaining & declining stocks 4:35 p.m. Dec. 9, 2011 - Kate Gibson
Thursday’s biggest gaining & declining stocks 3:59 p.m. June 30, 2011 - Kate Gibson
Cell Therapeutics tumbles over offerings 8:09 a.m. June 30, 2011 - MarketWatch.com

Insider Trading Alert - IRET, CTIC And RKUS Traded By Insiders 10:30 a.m. Jan. 8, 2015 - TheStreet.com
Insider Trading Alert - CTIC, FXCM And CRM Traded By Insiders 10:45 a.m. Dec. 22, 2014 - TheStreet.com
2015 Biotech Drug/Stock Outlook: Here's What You Need to Know 9:20 a.m. Dec. 17, 2014 - TheStreet.com
Where Are They Now? A Look Back at the Best & Worst Biotech CEOs 11:20 a.m. Dec. 16, 2014 - TheStreet.com
Insider Trading Alert - CSU, IRBT And CTIC Traded By Insiders 10:45 a.m. Dec. 8, 2014 - TheStreet.com
CTI BioPharma earns $15M milestone 7:46 a.m. Dec. 4, 2014 - Seeking Alpha
Five Biotech Firms Whose Stock-Promoting Efforts Didn't Pay Off 11:00 a.m. Dec. 2, 2014 - TheStreet.com
Incyte Building Blockbuster Drug One Disease At A Time 2:58 p.m. Nov. 17, 2014 - Investors Business Daily
Insider Trading Alert - CTIC, SAM And DGI Traded By Insiders 11:00 a.m. Nov. 7, 2014 - TheStreet.com
10-Q: CTI BIOPHARMA CORP 5:12 a.m. Oct. 31, 2014 - Edgar Online - (EDG = 10Q, 10K)
CTI BioPharma's (CTIC) CEO James Bianco on Q3 2014 Results - Earnings Call Transcript 2:10 a.m. Oct. 30, 2014 - Seeking Alpha
CTI BioPharma (CTIC) Q3 2014 Results - Earnings Call Webcast 3:25 p.m. Oct. 29, 2014 - Seeking Alpha
InsiderInsights.com Daily Round Up 9/24/14: Mercer International, OPKO Health, New Media, CTI BioPharma 7:17 a.m. Sept. 25, 2014 - Seeking Alpha
Merrimack Does Well to License Marginal Cancer Drug to Baxter 7:14 a.m. Sept. 24, 2014 - TheStreet.com
CTI BioPharma and Servier collaborate on cancer drug 7:19 a.m. Sept. 17, 2014 - Seeking Alpha
SEC Slaps Biotech Hedge Fund for Short-Selling Violations 12:04 p.m. Sept. 16, 2014 - TheStreet.com
CTI BioPharma set for gap up at the open 7:00 a.m. Sept. 9, 2014 - Seeking Alpha
Insider Trading Alert - MTDR, ABCO And CTIC Traded By Insiders 9:15 a.m. Aug. 18, 2014 - TheStreet.com
Insider Trading Alert - CMS, CTIC And WFT Traded By Insiders 9:15 a.m. Aug. 7, 2014 - TheStreet.com
CTI BioPharma's (CTIC) CEO Jim Bianco on Q2 2014 Results - Earnings Call Transcript 9:56 p.m. Aug. 4, 2014 - Seeking Alpha

CTI BioPharma Appoints Alan K. Burnett, M.D. As Therapeutic Area Lead, Myeloid Diseases 1:30 a.m. Jan. 12, 2015 - PR Newswire - PRF
CTI BioPharma Announces 2015 Outlook and Recent Drug Portfolio Progress 1:30 a.m. Jan. 8, 2015 - PR Newswire - PRF
CTI BioPharma Announces Presentation of Data Demonstrating Pacritinib Overrides Stromal Mediated Resistance in FLT3-ITD Positive AML Cells 1:30 a.m. Dec. 9, 2014 - PR Newswire - PRF
CTI BioPharma Announces Comprehensive Kinome Analysis that Demonstrates Pacritinib Inhibits Kinases Linked to a Spectrum of Blood-Related Cancers 12:00 p.m. Dec. 6, 2014 - PR Newswire - PRF
CTI BioPharma Receives $15 Million Milestone Payment for TRISENOX® 1:30 a.m. Dec. 4, 2014 - PR Newswire - PRF
Technical Scrutiny on Biotech Stocks - CTI BioPharma, Vertex Pharma, Progenics Pharma, iBio, and NewLink Genetics 8:45 a.m. Dec. 2, 2014 - PR Newswire - PRF
CTI BioPharma Announces Data Presentations at the 56th American Society of Hematology Annual Meeting 1:30 a.m. Dec. 1, 2014 - PR Newswire - PRF
CTI BioPharma to Present at the Upcoming Investor Conferences 1:30 a.m. Nov. 17, 2014 - PR Newswire - PRF
CTI BioPharma Prices Underwritten Public Offering of $35 Million of Convertible Preferred Stock 9:15 a.m. Nov. 7, 2014 - PR Newswire - PRF
CTI BioPharma Announces Proposed Public Offering of Convertible Preferred Stock 4:15 p.m. Nov. 6, 2014 - PR Newswire - PRF
CTI BioPharma Reports Third Quarter 2014 Financial Results 3:01 p.m. Oct. 29, 2014 - PR Newswire - PRF
CTI Acquires Exclusive Worldwide License to Tosedostat, a Selective Oral Anti-Cancer Therapy 1:30 a.m. Oct. 27, 2014 - PR Newswire - PRF
CTI BioPharma to Report Third Quarter 2014 Financial Results on October 29, 2014 12:30 a.m. Oct. 20, 2014 - PR Newswire - PRF
Technical Updates on Health Care Sector Stocks - AstraZeneca, Novartis, Salix Pharma, Inovio Pharma, and CTI BioPharma 8:15 a.m. Oct. 6, 2014 - PR Newswire - PRF
CTI BioPharma And Servier Announce Exclusive License And Collaboration Agreement To Develop And Commercialize PIXUVRI® 12:30 a.m. Sept. 17, 2014 - PR Newswire - PRF
Momentum Indicators for Biotech Stocks -- Exact Sciences, BioCryst Pharma, Spectrum Pharma, Aeterna Zentaris, and CTI BioPharma 7:50 a.m. Aug. 25, 2014 - PR Newswire - PRF
FDA Grants Fast Track Designation to CTI BioPharma's Pacritinib, a Novel JAK2 Inhibitor for the Treatment of Myelofibrosis 12:30 a.m. Aug. 7, 2014 - PR Newswire - PRF
CTI BioPharma Reports Second Quarter 2014 Financial Results 3:01 p.m. Aug. 4, 2014 - PR Newswire - PRF
The Federal Reserve Playing Analyst Damaging to Biotechnology Companies 9:06 a.m. July 30, 2014 - ACCESSWIRE
CTI BioPharma to Report Second Quarter 2014 Financial Results on August 4, 2014 12:30 a.m. July 28, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Vermiculus Unveils VeriIndex: A Game-Changer for Indices

Standing on the Precipice of Index Innovation There’s a seismic shift rumbling through Vermiculus as they roll out their latest brainchild, the VeriIndex. This isn’t just your typical release; it’s the kind of shakeup that slaps you awake like a splash of cold water. Ever since they burst onto the scene in 2020, Vermiculus has been stirring the pot of exchange...

American Lung Association Tackles Indoor Pollution

The Unseen Threat Lurking Indoors When you think about air pollution, your mind probably jumps to smog-choked city streets. But, surprise! The air inside your cozy living room could actually be pulling a fast one on you, being two to five times filthier than what’s outside. Now, that’s a hair-raising thought. A Closer Look at Indoor Air Hazards Folks don’t usually...

VIAVI's 37% NetSecOps Uptick: A Mixed Bag for Firms

Networking and Security: The Clash of the Titans The IT world sure loves mixing and matching its acronyms these days, doesn’t it? VIAVI Solutions, an ace in hybrid network-security operations, just released their 18th annual 'State of the Network' study. Tipping the hat to progress, they've reported a 37% jump in firms that have embraced NetSecOps over the past year....

Moises and SoundCloud Join Forces to Empower Musicians

Paving the Way for Artist Empowerment You ever wake up and feel like the music world just shifted? Like the landscape just got smoother for artists trying to juggle creativity and business without losing their minds? Well, Moises and SoundCloud teaming up might be just that seismic shift. Playing in the Big Leagues with Moises' Creative Suite Let's not fool...

Greenland Energy Board Reshuffle: McIllree Exits

A Change in Greenland Energy's Lineup Well, folks, the wheel keeps turning at Greenland Energy Company (NASDAQ:GLND). Roderick McIllree has decided to step off the Board of Directors' carousel, effective immediately. And nope, there wasn't a classic showdown or any disagreement on the table. This exit is as drama-free as they come—just him stepping aside, leaving the...

European Flavors: A Halloween Food Revolution

Who would've thought Halloween would toss a spin on fine dining? What's usually known for candy corn and spooky costumes has teamed up with European flavors for a night unlike any other. And we're talking more than just trick-or-treating here, folks. A New Kind of Halloween Spread This year, The Charming Taste of Europe has thrown itself into the Halloween festivities,...

Coles Teams Up with Coveo to Boost Online Grocery Shopping

Coles and Coveo: A Tech Partnership Worth Watching Buckle up, folks, because Coles Group Limited has chosen Coveo, the hotshot in AI-relevance, to revamp the online shopping landscape for its grocery business. Let's break down why this matters for both the grocery shopper hustling between work and carbs and the savvy investor eyeing the digital retail frontier. Enhancing...

School Safety: Revamping Response Coordination

Revamp in Emergency Training for School Incidents No longer can schools afford the luxury of uncoordinated chaos during emergencies. Today, the firepower behind the National Center for Integrated Emergency Response (NCIER) comes from the realization that courage alone doesn't cut it. It's about time someone put the pieces together, getting cops, fire, school staff, and...

Top Seedz: Seeds Drive Growth in Crowded Cracker Market

Breaking the Cracker Mold with Seeds Ever thought crackers could be more than just a canvas for cheese? Well, Top Seedz out of Buffalo is redefining the snack aisle with its seed-centric approach. In a whopping $25 billion global cracker market, this woman-owned outfit is carving out its niche by flipping conventional recipes on their heads. They're not just tossing seeds...

Duolingo Faces Class Action: Investors Brace for Impact

Going Beyond Language Learning Hype Listen, it's not every day you wake up to a lawsuit calling out one of those seemingly indestructible tech darlings. Well, Duolingo (NASDAQ: DUOL) is caught in the crosshairs now. They face allegations of pulling the wool over investors' eyes about their monetization and growth tactics. If you snapped up some stock between May 2, 2025,...